thenewsfacts.com
  • Home
  • Latest News
  • Trending News
  • Technology
  • entertainment
  • Sports
  • Business
thenewsfacts.comthenewsfacts.com
Font ResizerAa
Search
  • Home
  • Latest News
  • Trending News
  • Technology
  • entertainment
  • Sports
  • Business
Follow US
© thenewsfacts : All Rights Reserved.

Home » Beware of New COVID19 Mutant Strain XE – WHO Warns

COVID-19

Beware of New COVID19 Mutant Strain XE – WHO Warns

TheNewsFacts
Last updated: April 9, 2022 7:32 pm
TheNewsFacts
Share
Beware of New COVID19 Mutant Strain XE - WHO Warns
SHARE

Beware of new Covid19 Mutant Strain XE, WHO has revealed, the 2nd Omicron Recombinant Variant XE has to be in the watch list, this comes after the Omicron, Delta recombinants variant.

World Health Organisation (WHO) warned of the 2nd COVID mutant strain XE (hybrid strain of 2 Omicron subvariants) stating that early studies indicate that its growth rate advantage is ~10% as compared to BA.2. So far, three hybrid or recombinant viruses have been detected – XD, XE, XF – (two are combination of Delta and Omicron and the third is the hybrid strain of 2 Omicron subvariants).

A UK Health Security Agency (UKHSA) recently revealed in a study that currently as many are 3 hybrid COVID variants are circulating. The two different combinations of Delta and BA.1 are XD and XF. The third is XE.

XD is the new name for the French Delta x BA.1 lineage. It contains the Spike protein of BA.1 and the rest of the genome from Delta. It currently comprises several 10s of sequences.

XF is a UK Delta x BA.1 lineage. It has the Spike and structural proteins from BA.1 but the 5′ part of its genome from Delta. It comprises several tens of sequences currently.

XE is a large UK BA.1 x BA.2 lineage. It has the Spike and structural proteins from BA.2 but the 5′ part of its genome from BA.1. It comprises several hundred sequences at present.

After Omicron, Delta recombinant, WHO Warns of New Covid19 Mutant Strain XE

The World Health Organization issued a report yesterday with some preliminary findings about XE, reports said.

“The XE recombinant was first detected in the United Kingdom on 19 January and >600 sequences have been reported and confirmed since,” reads the WHO document. “Early-day estimates indicate a community growth rate advantage of ~10% as compared to BA.2, however this finding requires further confirmation.”

TAGGED:Covid19 XE VariantNew Mutant Strain XEWHO Covid19 Warning
Share This Article
Email Copy Link Print
Previous Article Say Goodbye to Covid19 Masks in New Delhi, Maharashtra Say Goodbye to Covid19 Masks in New Delhi, Maharashtra
Next Article Sri Lanka News : People Face State of Emergency, Big Unrest Sri Lanka News : People Face State of Emergency, Big Unrest

Your Trusted Source for Accurate and Timely Updates!

We're committed to providing accurate and unbiased news as it unfolds, earning the trust of a large audience. Stay informed with our news updates on the latest events and trends, keeping you ahead of the curve.
FacebookLike
XFollow
InstagramFollow

Popular Posts

From Hero to Heartbreak: Andy Murray’s Wimbledon’23 Dreams Crushed by Tsitsipas

In a thrilling second-round match at Wimbledon, Andy Murray battled World No. 5 Stefanos Tsitsipas,…

By
TheNewsFacts

The Rage of Kaantha’ is the New Rap Anthem of India

October 30, 2025: The first beats of The Rage of Kaantha are here, and they’ve…

By
NewsFacts Bureau

Your Antibody is Highly Protective Against SARS-Cov-2 Variants- Research

In a new research Researchers at the Washington University School of Medicine, St. Louis, revealed…

By
TheNewsFacts

You Might Also Like

COVID Vaccine for 15-18 Years: Over 50% Children Gets COVAXIN
COVID Vaccines

COVID Vaccine for 15-18 Years: Over 50% Children Gets COVAXIN

By
TheNewsFacts
Covid recovery rate in India
COVID-19

Covid recovery rate in India shows a big jump

By
TheNewsFacts
Vice President Venkaiah Naidu Lauds Bharat Biotech for developing an effective COVAXIN in a very short time frame
COVID-19

Vice President Venkaiah Naidu Lauds Bharat Biotech for developing an effective COVAXIN in a very short time frame

By
TheNewsFacts
India's COVAXIN, Long Awaited in the US to be Evaluated by FDA
COVID Vaccines

India’s COVAXIN, Long Awaited in the US to be Evaluated by FDA

By
TheNewsFacts
thenewsfacts thenewsfacts

About US


TheNewsFacts: Brings you the interesting facts, news facts and updates from India an the world across politics, tech, entertainment, business, tending, and more. We deliver what you love to read.
Top Categories
  • Latest News
  • Trending News
  • Paris Olympics 2024
  • Sports
  • Entertainment
  • Business
  • Technology
Usefull Links
  • About The News Facts
  • Latest News
  • Privacy Policy
  • Editorial Policy
  • Disclaimer
  • Contact Us
Follow us
Facebook Twitter Instagram

© thenewsfacts. All Rights Reserved.

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?